Related Experiment Video
Updated: Sep 24, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Association of C-Terminal Pro-Endothelin-1 with Mortality in the Population-Based KORA F4 Study
Cornelia Then1,2, Chaterina Sujana2,3,4, Christian Herder5,6,7
1Department of Internal Medicine IV, University Hospital of Ludwigs-Maximilians-University Munich, Munich, Germany.
Insights
C-terminal pro-endothelin-1 (CT-proET-1) is a risk marker for all-cause mortality, independent of cardiovascular disease and inflammation. This study found CT-proET-1 associated with increased mortality but not cardiovascular events or atherosclerosis markers.
Area of Science:
- Cardiovascular Research
- Metabolic Disease Research
- Biomarker Discovery
Background:
- Endothelin-1 and its precursor CT-proET-1 are implicated in metabolic disorders, inflammation, and cardiovascular events.
- Previous studies suggest a link between CT-proET-1 and adverse health outcomes in specific populations.
Purpose of the Study:
- To investigate the association of CT-proET-1 with cardiovascular events, mortality, carotid intima-media thickness, subclinical inflammation biomarkers, and adipokines.
- To analyze these associations within a general population-based study.
Main Methods:
- Utilized data from the KORA F4 study with a median follow-up of 9.1 years.
- Employed multivariable regression and Cox proportional hazard models, adjusting for numerous cardiovascular risk factors.
- Corrected for multiple testing using the Bonferroni method.
Main Results:
- CT-proET-1 was significantly associated with increased cardiovascular and all-cause mortality (HRs 1.66 and 2.03, respectively).
- No association was found with cardiovascular events, but an inverse association with carotid intima-media thickness was observed.
- CT-proET-1 correlated positively with several subclinical inflammation biomarkers and some adipokines.
Conclusions:
- CT-proET-1 serves as a risk marker for all-cause mortality, potentially independent of vascular endothelin-1 actions, cardiovascular disease, and inflammation.
- The findings highlight the complex role of endothelin-1 pathways and the indicator function of CT-proET-1.
Introduction:
Endothelin-1 and its prohormone C-terminal pro-endothelin-1 (CT-proET-1) have been linked to metabolic alterations, inflammatory responses and cardiovascular events in selected study populations. We analyzed the association of CT-proET-1 with cardiovascular events and mortality, carotid intima-media-thickness as surrogate for early atherosclerotic lesions, biomarkers of subclinical inflammation and adipokines in a population-based study.
Methods:
The cross-sectional and prospective analyses used data from the KORA F4 study with a median follow-up time of 9.1 (8.8-9.4) years. Data on CT-proET-1 and mortality were available for 1554 participants, data on the other outcomes in subgroups (n = 596-1554). The associations were estimated using multivariable linear regression and Cox proportional hazard models adjusted for sex, age, body mass index, estimated glomerular filtration rate, arterial hypertension, diabetes, low-density and high-density lipoprotein cholesterol, current and former smoking and physical activity. The Bonferroni method was used to correct for multiple testing.
Results:
In the fully adjusted model, CT-proET-1 was associated with cardiovascular (hazard ratio (HR) per standard deviation increase: 1.66; 95% confidence interval (CI): 1.10-2.51; p = 0.017) and all-cause mortality (HR: 2.03; 95% CI 1.55-2.67; p < 0.001), but not with cardiovascular events, and was inversely associated with the intima-media thickness (β: -0.09 ± 0.03; p = 0.001). CT-proET-1 was positively associated with five out of ten biomarkers of subclinical inflammation and with two out of five adipokines after correction for multiple testing. After inclusion of biomarkers of subclinical inflammation in the Cox proportional hazard model, the association of CT-proET-1 with all-cause mortality persisted (p < 0.001).
Conclusion:
These results emphasize the complexity of endothelin-1 actions and/or indicator functions of CT-proET-1. CT-proET-1 is a risk marker for all-cause mortality, which is likely independent of vascular endothelin-1 actions, cardiovascular disease and inflammation.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Intracellular Signaling Affects Focal Adhesions
Some...
Hypertension II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension III: Clinical Manifestations and Diagnostic Studies